After Blood Plasma Emergency Use Authorization, Can Takeda Develop A More Potent Alternative?
Hyperimmune Globulin Could Prove Superior
After the FDA's emergency use authorization for convalescent plasma, pushed on by President Trump, an alliance of firms is working with the NIH to conduct a robust study of a potentially more potent alternative.
